Effect of coadministration of ezetimibe with statin therapy versus statin therapy alone on flow mediated vasodilation in patients with coronary artery disease.
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2009
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin
- Indications Coronary artery disease; Dyslipidaemias
- Focus Pharmacodynamics
- Acronyms CEZAR
- 01 Jul 2009 Primary endpoint 'Change in flow-mediated dilation' has been met.
- 01 Jul 2009 Results published in Atherosclerosis.
- 03 Oct 2008 New trial record.